• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

1-Isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (CAS No. 2096332-54-4): A Comprehensive Overview

1-Isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (CAS No. 2096332-54-4) is a versatile compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrazoles and is characterized by its unique structural features and potential biological activities. The presence of the isobutyl group and the dioxaborolane moieties imparts specific chemical and biological properties that make it a valuable candidate for various applications.

The chemical structure of 1-isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is particularly noteworthy. The pyrazole ring is a five-membered heterocyclic compound with two nitrogen atoms at positions 1 and 3. The substitution with the isobutyl group at position 1 and the dioxaborolane moieties at positions 3 and 5 adds complexity and functionality to the molecule. The dioxaborolane groups are known for their ability to participate in Suzuki-Miyaura coupling reactions, making this compound a useful intermediate in organic synthesis.

In recent years, the interest in boron-containing compounds has surged due to their diverse applications in medicinal chemistry. The dioxaborolane moiety in particular has been extensively studied for its role in drug discovery and development. This functional group can enhance the solubility and bioavailability of molecules, making them more suitable for pharmaceutical applications. Additionally, the boron atom can participate in various chemical reactions that are crucial for the synthesis of complex molecules.

The biological activity of 1-isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole has been explored in several studies. Pyrazoles are known for their anti-inflammatory and analgesic properties, which are attributed to their ability to inhibit cyclooxygenase (COX) enzymes. The presence of the isobutyl group and the dioxaborolane moieties may further modulate these properties by affecting the binding affinity and selectivity of the molecule towards its target enzymes.

Beyond its potential as an anti-inflammatory agent, this compound has also shown promise in other therapeutic areas. For instance, recent research has indicated that certain pyrazole derivatives can exhibit antitumor activity by targeting specific signaling pathways involved in cancer progression. The structural features of 1-isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, particularly the presence of the dioxaborolane groups, may contribute to its ability to interact with these pathways effectively.

In addition to its biological activities, the synthetic accessibility of 1-isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is another factor that makes it an attractive candidate for further investigation. The Suzuki-Miyaura coupling reaction is a well-established method for introducing aryl or vinyl groups into organic molecules. The presence of the dioxaborolane moieties in this compound facilitates such reactions, allowing for the efficient synthesis of a wide range of derivatives with varying functional groups.

The stability and reactivity of this compound have also been studied extensively. Under appropriate conditions, it can be stored without significant degradation. However, care must be taken to avoid exposure to moisture and air to prevent hydrolysis of the boronate esters. This stability makes it suitable for long-term storage and use in various laboratory settings.

In conclusion, 1-isobutyl-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (CAS No. 2096332-54-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it a valuable candidate for further investigation and development into novel therapeutic agents. As research in this area continues to advance,< strong>this compound is likely to play an increasingly important role in drug discovery and development efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)